-
Mstack launches Chemstack AI – a revolutionary AI-led R&D platform; achieves 10x revenue growth as chemical industry faces supply chain crisis - 2 days ago
-
PROLOG FULFILMENT APPOINTS NEW SENIOR GENERAL MANAGER TO DRIVE OPERATIONAL EXCELLENCE - September 24, 2025
-
SURECAM TEAMS UP WITH ENTERPRISE MOBILITY TO SHOWCASE VIDEO TELEMATICS INNOVATION - September 24, 2025
-
HAULIERS URGED TO STAY FOCUSED ON ICS2 CUSTOMS CHANGES DESPITE DELAYS - September 23, 2025
-
GOPLASTICPALLETS.COM LAUNCHES NEW FREEZER SPACERS TO HELP FOOD MANUFACTURERS BOOST COLD CHAIN EFFICIENCY - September 23, 2025
-
Westexe Takes Centre Stage to Scoop Prestigious Archies Award - September 22, 2025
-
Jungheinrich scores A* in supporting educational resources supplier’s zero-carbon journey - September 22, 2025
-
RITE-HITE EXPANDS VEHICLE RESTRAINT PORTFOLIO WITH NEW USER-FRIENDLY MANUAL ERGONOMIC WHEEL-LOK - September 17, 2025
-
Simmi London steps up delivery experience with Scurri Connect - September 17, 2025
-
Rebecca Smith to bring fresh perspective to UKMHA Board After Exciting Appointment - September 17, 2025
Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper
The vital role that temperature-controlled packaging plays in transporting pharmaceuticals around the world has been highlighted in a new white paper from Tower Cold Chain, with the aim of helping stakeholders find the right solution for their needs.
Compounded by the demands of the COVID-19 pandemic, the white paper provides practical advice on the various options available, with insight delivered by seven leading industry experts from across the supply chain. These include senior decision makers from Johnson & Johnson, DHL and LOT Polish Airlines, who deliver an unbiased guide that is ideal for specifiers in pharmaceuticals, 3PL and air freight looking to make informed choices.
Free to download from the Tower website, the white paper – titled ‘Passive v Active in a globally disrupted age’ – collates the key findings of a 90-minute webinar organised by Tower in late 2021. Amongst the topics covered are the rapid changes affecting the industry; the new challenges that are arising in delivering vaccines to remote areas; and the considerations that must be made in selecting the optimum container type for the task.
At the heart of the publication is an assessment of the relative merits of Active, Passive and Hybrid temperature-controlled packaging solutions with detailed insight on their use across the global pharmaceutical supply chain.
In an unbiased review of the technologies the white paper identifies a place for all types of temperature-controlled solutions within the market.
“In some circumstances, active methods are ideal. In others, passive is the only sensible choice to de-risk the shipment,” explains Kevin Doran, Global Head of Supply Chain at Tower Cold Chain.
“When it comes to patient care and the effective delivery of critical pharmaceuticals there’s no benefit in being partisan. We felt it was vital that decision makers can get a balanced view, which is why this white paper brings together a wide range of voices to survey the whole landscape and identify the scenarios for the best use of each technology.
“We’re grateful to all of the experts who gave their time and provide such a rich source of insight and information – and we look forward to sharing it with others.”
The white paper can be downloaded here.